{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T04:46:43.578776+00:00","published_at":"2026-10-17T04:46:43.578776+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:ameet-mallik","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Ameet Mallik","to_label":"ADC Therapeutics SA","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:jean-pierre-bizzari","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Jean-Pierre Bizzari","to_label":"ADC Therapeutics SA","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:peter-hug","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Peter Hug","to_label":"ADC Therapeutics SA","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:robert-azelby","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Robert Azelby","to_label":"ADC Therapeutics SA","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:ron-squarer","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Ron Squarer","to_label":"ADC Therapeutics SA","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:timothy-coughlin","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Timothy Coughlin","to_label":"ADC Therapeutics SA","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:tyrell-j-rivers","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Tyrell J. Rivers","to_label":"ADC Therapeutics SA","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:victor-sandor","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Victor Sandor","to_label":"ADC Therapeutics SA","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:viviane-monges","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Viviane Monges","to_label":"ADC Therapeutics SA","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:9:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:jose-pepe-carmona","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Jose Pepe Carmona","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:10:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:mohamed-zaki","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Mohamed Zaki","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:12:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"seat_on","from_id":"alpha:person:peter-j-graham","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Peter J. Graham","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:audit","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Audit","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:chairs:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19:committee:adc-therapeutics-sa:audit","relationship_type":"chairs","from_id":"alpha:person:timothy-coughlin","to_id":"alpha:committee:adc-therapeutics-sa:audit","from_label":"Timothy Coughlin","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19:committee:adc-therapeutics-sa:audit","relationship_type":"member_of","from_id":"alpha:person:robert-azelby","to_id":"alpha:committee:adc-therapeutics-sa:audit","from_label":"Robert Azelby","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:audit-chair","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Audit · Chair","to_label":"ADC Therapeutics SA","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15:committee:adc-therapeutics-sa:audit-chair","relationship_type":"member_of","from_id":"alpha:person:timothy-coughlin","to_id":"alpha:committee:adc-therapeutics-sa:audit-chair","from_label":"Timothy Coughlin","to_label":"Audit · Chair","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:audit-compensation","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Audit; Compensation","to_label":"ADC Therapeutics SA","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13:committee:adc-therapeutics-sa:audit-compensation","relationship_type":"member_of","from_id":"alpha:person:robert-azelby","to_id":"alpha:committee:adc-therapeutics-sa:audit-compensation","from_label":"Robert Azelby","to_label":"Audit; Compensation","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:audit-nominating-and-governance","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Audit; Nominating and Governance","to_label":"ADC Therapeutics SA","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18:committee:adc-therapeutics-sa:audit-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:viviane-monges","to_id":"alpha:committee:adc-therapeutics-sa:audit-nominating-and-governance","from_label":"Viviane Monges","to_label":"Audit; Nominating and Governance","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:compensation","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Compensation","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922","alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:chairs:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23:committee:adc-therapeutics-sa:compensation","relationship_type":"chairs","from_id":"alpha:person:peter-hug","to_id":"alpha:committee:adc-therapeutics-sa:compensation","from_label":"Peter Hug","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23:committee:adc-therapeutics-sa:compensation","relationship_type":"member_of","from_id":"alpha:person:robert-azelby","to_id":"alpha:committee:adc-therapeutics-sa:compensation","from_label":"Robert Azelby","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Compensation · Chair; Nominating and Governance","to_label":"ADC Therapeutics SA","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:peter-hug","to_id":"alpha:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance","from_label":"Peter Hug","to_label":"Compensation · Chair; Nominating and Governance","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:nominating-and-governance","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Nominating and Governance","to_label":"ADC Therapeutics SA","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:chairs:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27:committee:adc-therapeutics-sa:nominating-and-governance","relationship_type":"chairs","from_id":"alpha:person:jean-pierre-bizzari","to_id":"alpha:committee:adc-therapeutics-sa:nominating-and-governance","from_label":"Jean-Pierre Bizzari","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27:committee:adc-therapeutics-sa:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:peter-hug","to_id":"alpha:committee:adc-therapeutics-sa:nominating-and-governance","from_label":"Peter Hug","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27","evidence_ids":["alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8:company:886b19eb-fab1-4a15-829d-8b90daff05df","relationship_type":"committee_of","from_id":"alpha:committee:adc-therapeutics-sa:nominating-and-governance-chair","to_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","from_label":"Nominating and Governance · Chair","to_label":"ADC Therapeutics SA","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8:committee:adc-therapeutics-sa:nominating-and-governance-chair","relationship_type":"member_of","from_id":"alpha:person:jean-pierre-bizzari","to_id":"alpha:committee:adc-therapeutics-sa:nominating-and-governance-chair","from_label":"Jean-Pierre Bizzari","to_label":"Nominating and Governance · Chair","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"]}]},"claims":[{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ameet-mallik","object_label":"Ameet Mallik","object_source_name_forms":[],"value":"Ameet Mallik: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ameet-mallik","name":"Ameet Mallik"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jean-pierre-bizzari","object_label":"Jean-Pierre Bizzari","object_source_name_forms":[],"value":"Jean-Pierre Bizzari: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jean-pierre-bizzari","name":"Jean-Pierre Bizzari"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:9","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jose-pepe-carmona","object_label":"Jose Pepe Carmona","object_source_name_forms":[],"value":"Jose Pepe Carmona: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jose-pepe-carmona","name":"Jose Pepe Carmona"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:10","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mohamed-zaki","object_label":"Mohamed Zaki","object_source_name_forms":[],"value":"Mohamed Zaki: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mohamed-zaki","name":"Mohamed Zaki"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-hug","object_label":"Peter Hug","object_source_name_forms":[],"value":"Peter Hug: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-hug","name":"Peter Hug"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:12","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-j-graham","object_label":"Peter J. Graham","object_source_name_forms":[],"value":"Peter J. Graham: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-j-graham","name":"Peter J. Graham"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-azelby","object_label":"Robert Azelby","object_source_name_forms":[],"value":"Robert Azelby: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-azelby","name":"Robert Azelby"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ron-squarer","object_label":"Ron Squarer","object_source_name_forms":[],"value":"Ron Squarer: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ron-squarer","name":"Ron Squarer"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-coughlin","object_label":"Timothy Coughlin","object_source_name_forms":[],"value":"Timothy Coughlin: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-coughlin","name":"Timothy Coughlin"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tyrell-j-rivers","object_label":"Tyrell J. Rivers","object_source_name_forms":[],"value":"Tyrell J. Rivers: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tyrell-j-rivers","name":"Tyrell J. Rivers"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:victor-sandor","object_label":"Victor Sandor","object_source_name_forms":[],"value":"Victor Sandor: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:victor-sandor","name":"Victor Sandor"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:viviane-monges","object_label":"Viviane Monges","object_source_name_forms":[],"value":"Viviane Monges: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:viviane-monges","name":"Viviane Monges"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Timothy Coughlin; Members Timothy Coughlin (Chair); Robert Azelby; Viviane Monges","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Timothy Coughlin","members":[{"display_name":"Timothy Coughlin","person_slug":"timothy-coughlin","is_chair":true},{"display_name":"Robert Azelby","person_slug":"robert-azelby","is_chair":false},{"display_name":"Viviane Monges","person_slug":"viviane-monges","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Peter Hug; Members Peter Hug (Chair); Robert Azelby; Victor Sandor","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Peter Hug","members":[{"display_name":"Peter Hug","person_slug":"peter-hug","is_chair":true},{"display_name":"Robert Azelby","person_slug":"robert-azelby","is_chair":false},{"display_name":"Victor Sandor","person_slug":"victor-sandor","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Jean-Pierre Bizzari; Members Jean-Pierre Bizzari (Chair); Peter Hug; Viviane Monges","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Jean-Pierre Bizzari","members":[{"display_name":"Jean-Pierre Bizzari","person_slug":"jean-pierre-bizzari","is_chair":true},{"display_name":"Peter Hug","person_slug":"peter-hug","is_chair":false},{"display_name":"Viviane Monges","person_slug":"viviane-monges","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.827,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.429},"diagnostics":{"published_claims":30,"factual_claims":30,"claims_with_linked_evidence":30,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:43.578776+00:00","observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":"2026-10-17T04:46:43.578776+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":30,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/adc-therapeutics-sa/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}